We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
(-2.1%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.7M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$34.3M |
| 3 |
Moderna
MRNA
|
+$29.3M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$18.3M |
| 5 |
Match Group
MTCH
|
+$9.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$35.7M |
| 2 |
Microsoft
MSFT
|
+$14.2M |
| 3 |
Apple
AAPL
|
+$13.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.28M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.19% |
| 2 | Financials | 13.17% |
| 3 | Healthcare | 12.67% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
2501
Tectonic Therapeutic
TECX
$720M
| $81.8K | ﹤0.01% |
1,221
+1,096
| +877% | +$89.9K |
|
2502
Civista Bancshares
CIVB
$597M
| $80.5K | ﹤0.01% |
3,464
-3,645
| -51% | -$83.7K |
|
2503
Allient
ALNT
$1.94B
| $79.1K | ﹤0.01% |
2,529
-2,652
| -51% | -$86.8K |
|
2504
Entravision Communication
EVC
$832M
| $78.3K | ﹤0.01% |
11,027
-11,953
| -52% | -$80.7K |
|
2505
XBiotech
XBIT
$75M
| $76.3K | ﹤0.01% |
+5,892
| New | +$93.9K |
|
|
AKTS
2506
DELISTED
Akoustis Technologies Inc
AKTS
| $75.6K | ﹤0.01% |
7,791
-8,187
| -51% | -$78.5K |
|
|
KBAL
2507
DELISTED
Kimball International
KBAL
| $75.2K | ﹤0.01% |
6,716
-6,989
| -51% | -$85.8K |
|
2508
Barnes & Noble Education
BNED
$417M
| $74.3K | ﹤0.01% |
74
-75
| -50% | -$66.1K |
|
2509
Marcus Corp
MCS
$914M
| $72.6K | ﹤0.01% |
4,158
-5,085
| -55% | -$82.9K |
|
2510
Motorcar Parts of America
MPAA
$230M
| $71.1K | ﹤0.01% |
3,648
-4,352
| -54% | -$91.1K |
|
|
ESPR
2511
DELISTED
Esperion Therapeutics
ESPR
| $71K | ﹤0.01% |
5,894
-6,792
| -54% | -$98.9K |
|
2512
Kopin
KOPN
$930M
| $70K | ﹤0.01% |
13,644
-14,585
| -52% | -$88.5K |
|
|
LONA
2513
LeonaBio Inc
LONA
$73.9M
| $69.2K | ﹤0.01% |
738
-797
| -52% | -$81.1K |
|
2514
Cartesian Therapeutics
RNAC
$263M
| $68.5K | ﹤0.01% |
549
-656
| -54% | -$79.2K |
|
2515
Atossa Therapeutics
ATOS
$23.5M
| $64.9K | ﹤0.01% |
1,328
-1,605
| -55% | -$93.4K |
|
2516
Carter Bankshares
CARE
$717M
| $61.3K | ﹤0.01% |
+4,313
| New | +$53.3K |
|
2517
Aveanna Healthcare
AVAH
$1.97B
| $61.3K | ﹤0.01% |
7,647
-9,406
| -55% | -$91.2K |
|
2518
TETRA Technologies
TTI
$1.29B
| $58.7K | ﹤0.01% |
18,820
-27,463
| -59% | -$88.1K |
|
2519
Blue Bird Corp
BLBD
$2.04B
| $58K | ﹤0.01% |
2,782
-4,083
| -59% | -$90.6K |
|
2520
Titan International
TWI
$450M
| $57K | ﹤0.01% |
7,965
-11,326
| -59% | -$89.5K |
|
2521
InnovAge Holding
INNV
$1.42B
| $56K | ﹤0.01% |
8,476
| – | – |
|
2522
Karyopharm Therapeutics
KPTI
$46M
| $55.6K | ﹤0.01% |
637
-944
| -60% | -$98K |
|
|
SIEN
2523
DELISTED
Sientra, Inc.
SIEN
| $55K | ﹤0.01% |
959
-1,366
| -59% | -$93.3K |
|
2524
Universal Insurance Holdings
UVE
$1.18B
| $54.8K | ﹤0.01% |
4,204
-6,375
| -60% | -$87K |
|
2525
Dorian LPG
LPG
$1.91B
| $54.6K | ﹤0.01% |
4,400
-7,018
| -61% | -$87.7K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
- MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
- MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
- MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
- MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
- MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.
Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.